- CEO
- Tadashi Yasuda
- Full Time Employees
- 1,037
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- 1-3-7, Uchihiranomachi Chuo-ku Kyoto KY Japan 540-0037
- IPO Date
- Apr 1, 1997
- Business
- FALCO HOLDINGS Co., Ltd. primarily engages in the provision of clinical testing and dispensing pharmacy services in Japan. The company offers comprehensive clinical testing services including genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; it also provides genetic testing services. In addition, FALCO develops and markets in vitro diagnostics designed to meet unmet medical needs. The company operates in the dispensing pharmacies and drugstore sector and provides various medical information technology services, including the development and sale of medical chart systems such as HAYATE/NEO, a cloud-based electronic medical chart system for small and medium-sized hospitals, and @home Dr., an electronic medical chart for bedless clinics. FALCO targets medical institutions, healthcare providers, and pharmaceutical sectors primarily in Japan. The company was founded in 1962 and is headquartered in Osaka, Japan.
Recent major developments include an equity buyback program completed in 2025 and strategic transactions involving senior debt with companies such as Osisko and Glencore Canada Corporation. These transactions, which involved issuance and exercise of common share purchase warrants, are part of the company's financial restructuring efforts, effective from December 31, 2024. FALCO has also focused on expanding its medical IT services and clinical testing capabilities to further penetrate domestic healthcare markets. The company continues to advance its portfolio in genetic and clinical diagnostics while maintaining a strong presence in pharmacy dispensing and healthcare IT solutions.
FALCO operates through business segments that include Clinical Testing, Dispensing Pharmacy, and Medical IT, serving a broad customer base comprising hospitals, clinics, pharmacies, and healthcare companies within Japan. The company’s ongoing strategic emphasis on innovation in diagnostics and technology-enabled healthcare services supports its position in the Japanese medical services industry. It is publicly listed on the Tokyo Stock Exchange under the ticker 4671.T.
This description incorporates the latest operational changes and financial strategies of FALCO HOLDINGS Co., Ltd., reflecting its comprehensive product and service offerings along with recent major company events.